Boys Arnold & Co. Inc. Has $6.18 Million Stake in Aetna Inc. (AET)
Boys Arnold & Co. Inc. decreased its position in shares of Aetna Inc. (NYSE:AET) by 2.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,890 shares of the company’s stock after selling 840 shares during the quarter. Aetna comprises about 1.0% of Boys Arnold & Co. Inc.’s investment portfolio, making the stock its 24th largest holding. Boys Arnold & Co. Inc.’s holdings in Aetna were worth $6,184,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in AET. Bruderman Asset Management LLC acquired a new stake in Aetna in the second quarter worth about $106,000. Liberty Capital Management Inc. lifted its holdings in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after purchasing an additional 629 shares during the period. Guardian Life Insurance Co. of America lifted its holdings in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after purchasing an additional 9 shares during the period. Westside Investment Management Inc. lifted its holdings in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after purchasing an additional 400 shares during the period. Finally, Phocas Financial Corp. acquired a new stake in Aetna in the second quarter worth about $182,000. 89.45% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: This story was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://theolympiareport.com/2017/10/31/boys-arnold-co-inc-has-6-18-million-stake-in-aetna-inc-aet.html.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
Aetna Inc. (NYSE AET) traded down 0.756% during midday trading on Tuesday, hitting $169.935. The stock had a trading volume of 2,529,093 shares. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $184.98. The firm has a 50-day moving average price of $159.56 and a 200-day moving average price of $151.91. The firm has a market capitalization of $56.44 billion, a price-to-earnings ratio of 37.721 and a beta of 0.53.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.07 by $0.38. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.07 EPS. On average, equities research analysts anticipate that Aetna Inc. will post $9.49 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were paid a $0.50 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a yield of 1.17%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.
Several research firms recently weighed in on AET. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price objective on shares of Aetna in a report on Monday, October 23rd. BMO Capital Markets upped their price objective on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a report on Friday. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Argus reiterated a “buy” rating and issued a $185.00 price target (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Finally, BidaskClub cut shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Nine research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Aetna currently has a consensus rating of “Buy” and a consensus target price of $163.67.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.